We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

93 hedge funds and large institutions have $42.2M invested in Carisma Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.07% less ownership

Funds ownership: 1.29% → 1.22% (-0.07%)

5% less capital invested

Capital invested by funds: $44.5M → $42.2M (-$2.3M)

10% less funds holding

Funds holding: 103 → 93 (-10)

10% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 29

33% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 27

58% less call options, than puts

Call options by funds: $1.28M | Put options by funds: $3.08M

Holders
93
Holders Change
-10
Holders Change %
-9.71%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
26
Reduced
29
Closed
27
Calls
$1.28M
Puts
$3.08M
Net Calls
-$1.8M
Net Calls Change
-$1.14M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.57M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.18M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.9M
4
Prudential Financial
Prudential Financial
New Jersey
+$678K
5
Group One Trading
Group One Trading
Illinois
+$449K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$2.29M
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.93M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.25M
4
Norges Bank
Norges Bank
Norway
-$996K
5
Deutsche Bank
Deutsche Bank
Germany
-$750K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
76
Jacobs Levy Equity Management
New Jersey
$9K +$11.6K +577 New
HCMT
77
Highland Capital Management (Tennessee)
Tennessee
$8K – – –
PAG
78
Private Advisor Group
New Jersey
$8K – – –
CPA
79
Capital Performance Advisors
California
$7K +$10.1K +500 New
Belvedere Trading
80
Belvedere Trading
Illinois
$6K +$8.98K +446 New
AF
81
Allworth Financial
California
$5K – – –
IA
82
IFP Advisors
Florida
$4K – – –
TIM
83
Tortoise Investment Management
New York
$3K – – –
CAPTRUST Financial Advisors
84
CAPTRUST Financial Advisors
North Carolina
$2K – – –
RFA
85
Reilly Financial Advisors
California
$2K – – –
National Bank of Canada
86
National Bank of Canada
Quebec, Canada
$2K +$2.23K +111 New
AA
87
Ancora Advisors
Ohio
$1K – – –
SWM
88
Spire Wealth Management
Virginia
$1K – – –
CFRPA
89
Castle Financial & Retirement Planning Associates
New Jersey
$1K +$1.19K +59 New
Manulife (Manufacturers Life Insurance)
90
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$22 +$26.8K +1,329 New
Renaissance Technologies
91
Renaissance Technologies
New York
– -$1.25M -78,484 Closed
Norges Bank
92
Norges Bank
Norway
– -$996K -62,795 Closed
HF
93
HRT Financial
New York
– -$563K -35,526 Closed
Federated Hermes
94
Federated Hermes
Pennsylvania
– -$253K -15,945 Closed
State of Wisconsin Investment Board
95
State of Wisconsin Investment Board
Wisconsin
– -$175K -11,055 Closed
D.E. Shaw & Co
96
D.E. Shaw & Co
New York
– -$137K -8,654 Closed
Squarepoint
97
Squarepoint
New York
– -$69K -4,354 Closed
ECM
98
ExodusPoint Capital Management
New York
– -$46K -2,917 Closed
VEA
99
Virtus ETF Advisers
New York
– -$40K -2,501 Closed
Rafferty Asset Management
100
Rafferty Asset Management
New York
– -$23K -1,455 Closed
1 2 3
4
5

CARM Hedge Fund Activity: Q4 2021 in Review

93 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q4 2021, worth a combined $42.2M — down 5.2% from $44.5M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of CARM and 18 opened new positions — a net loss of 9 holders — while 29 trimmed existing stakes and 26 added.

The largest buyer was BlackRock, adding an estimated $2.57M. The largest seller was Two Sigma Investments, cutting an estimated $2.29M.

  • 93 institutional investors held Carisma Therapeutics (CARM) as of Q4 2021, down from 103 in Q3 2021.
  • Funds reported $42.2M of Carisma Therapeutics stock for Q4 2021, down 5.2% quarter-over-quarter.
  • 18 funds opened new Carisma Therapeutics positions in Q4 2021 and 27 closed out, a net change of -9 holders.
  • The largest Carisma Therapeutics buyer in Q4 2021 was BlackRock, an estimated $2.57M added.
  • The largest Carisma Therapeutics seller in Q4 2021 was Two Sigma Investments, an estimated $2.29M sold.

Based on aggregated 13F filings for Q4 2021.